In this podcast, Dr. Christopher Flowers discusses new research from the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition, including new treatments for non-Hodgkin lymphoma and models for predicting early disease progression. Read More >>
immunotherapy
January 25, 2023 · Brielle Gregory Collins, ASCO staff
December 19, 2022 · Greg Guthrie, ASCO staff
Read research from the December 2022 session of the ASCO Plenary Series, which explores combining immunotherapy for advanced non-small cell lung cancer with high PD-L1. Read More >>
December 12, 2022 · Greg Guthrie, ASCO staff
A study from China published in the Journal of Clinical Oncology has shown that CAR T-cell therapy that targets CD19 and CD22 is effective at treating recurrent or refractory acute lymphoblastic leukemia in children. Read More >>
November 10, 2022 · Brielle Gregory Collins, ASCO staff
Drs. David Ilson, Sumanta (Monty) Pal, and Tian Zhang discuss new research presented at the 2022 ESMO Congress, including studies about treating liver, colorectal, stomach, kidney, bladder, and prostate cancers. Read More >>
September 15, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in non-small cell lung cancer, non-Hodgkin lymphoma, Ewing sarcoma, and neuroblastoma. Read More >>